Universitary Expert Course In Therapeutic Uses of Cannabis
With Academic Endorsement and Certification from the Universidad Francisco de Vitoria – UFV Madrid (Spain)
Universitary Expert Course…
This Universitary Expert Course provides overview of the current situation of therapeutic cannabis, through a combination of sociological, biological and pharmaceutical knowledge, as described by the world’s leading experts in the field.
Through the evidence found, in archaeological sites around the world and in a multitude of ancient texts, the role of cannabis as medicine can be traced in the deep history of human society, spanning thousands of years and a variety of therapeutic applications. The last hundred years have witnessed controversy in the use of cannabis as a medicine. However, the landscape appears to be changing as the scientific community rediscovers, expands, and embraces knowledge about the clinical use of cannabis.
Module 1: History of Cannabis Therapeutics. 1 ECTS
Module 2: Changing Landscape of the Law. 1,5 ECTS
Module 3: The Endocannabinoid System. 3 ECTS
Module 4: Research, technology, and the evolution of cannabis therapy field. (3 ECTS)
Module 5: THC in effect. 3 ECTS
Module 6: Purity and Dosage. 1 ECTS
Module 7: Social Perceptions. 1,5 ECTS
Module 8: Business Models. 1 ECTS
Proyecto Fin de Experto. 5 ECTS
The Universitary Expert Course In Therapeutic Uses of Cannabis is delivered by tutors and experts of the highest standing and regard.
Social Anthropologist with extensive international experience in the field of Cannabis Therapeutics and its culture. He provided evidence in writing and in person to the House of Lords Select Committee on Science and Technology: Cannabis subcommittee. He has also provided expert evidence in the Sheriff and High Courts of Scotland and the Crown Courts of England; and has worked as a Consultant Anthropologist for the Metropolitan Police Special Intelligence Section. He produced a documentary in Amsterdam about coffee shop society and cannabis culture for Chanel Four television, transmitted within a tv special he devised call ‘Pot Night’. He was a Scientific Advisor to the Medicinal Cannabis Research Foundation. Research Director and Executive of the ISPS. Contributor to several books and International consultant and speaker. He holds two Masters degrees in Anthropology frm the University of Edinburgh, is a Fellow of the Royal Society of Arts and a Fellow of the Royal Anthropological Institute.
Julián Romero Paredes
Julián Romero Paredes is a Doctor of Pharmacy (Biochemistry and Molecular Biology) from the Complutense University of Madrid. He also has a degree in Ecclesiastical Sciences (Bachelor of Theology) from the Universidad Pontificia de Comillas. He has extensive teaching and research experience, especially focused on diseases of the Nervous System. Throughout his professional career, Dr. Romero has held positions in national and international centers, such as the University of Cantabria, Brown University (Providence, Rhode Island, USA) and the Medical College of Wisconsin (Milwaukee, Wisconsin, USA) and has been a staff researcher at the Alcorcón Foundation University Hospital. His research work has resulted in the publication of dozens of articles in international magazines, as well as several book chapters. He has also coordinated research projects on an ongoing basis for the past 20 years and has supervised several doctoral theses. He is currently the Academic Director of the Degree in Pharmacy at the Francisco de Vitoria University, where he has been a professor since 2000. He has been president of the Spanish Society for Research on Cannabinoids and his research group maintains collaborations with groups and companies of Spain, Great Britain, the United States, Israel and Italy, among others.
Director of Teaching.
Degree in Biology, specialized in molecular biology from the Autonomous University of Madrid. Doctoral thesis focused on the investigation of the molecular mechanisms underlying Huntington’s disease and its possible treatment with synthetic non-psychotomimetic cannnabinoid derivatives and their effect on neurogenesis and neuronal repair. Studied the role that THC exerts on the specification of layers during the development of the cerebral cortex. During the last stage I have combined this research activity with a teaching vocation in the degree programs in Biology, Biochemistry, Chemistry and Master in Biotechnology.
MedCann Campus Director
Psychologist from the Miguel de Cervantes European University of Valladolid (Spain).
Throughout his professional development he has started multiple projects related to top-of-the-line training and maintains a firm commitment to Innovation and Quality.
Since January 2019, he has directed the MedCann Campus, a specialized training and research space based on the therapeutic uses of cannabis.
Doctor in Biology from the UCM (1986). He is currently Professor of Biochemistry and Molecular Biology at the UCM School of Medicine. Along with his teaching activity in the field of Neurobiology, he has spent 39 years researching different CNS diseases. Currently, he is the PI of the CANNABINOIDES research group of the UCM, and also of the University Institute for Research in Neurochemistry, of the CIBER de Neurodegenerative Diseases and the Ramón y Cajal Institute for Health Research. The group’s activity is focused on studying the therapeutic potential of cannabinoids in neurodegenerative diseases, an activity in which it collaborates with several national and international groups, as well as with companies in the pharmaceutical and biotechnological field (GW Pharmaceuticals, Emerald Health Pharmaceuticals, ANKAR Pharma, Symrisey Roche). He has been President of the “International Cannabinoid Research Society” (2002–2003) and of the Spanish Society for Research on Cannabinoids (2007–2011).
Doctor Biochemistry Complutense University Madrid.
Member of the Complutense University Institute for Research in Neurochemistry. Postdoctoral position with an EMBO fellowship at the University of Dundee. His research is related to the role of the endocannabinoid system in the appearance and development of different types of tumors, among which glioblastomas stand out. The results obtained have allowed him to clinically explore the antitumor effect of the 155 cannabinoids. He has published more than 85 articles and reviews in international journals indexed in JCR, as well as several national and international book chapters. He is co-founder of the Spanish Observatory of Medicinal Cannabis and member of the Spanish Society for Research on Cannabinoids.
President and founder of the pioneer of cannabinoid medicine, GW Pharma.
Dr. Geoffrey Guy is the founder of the Company and has served as President since 1998. Dr. Guy is the creator of Sativex and Epidiolex and continues to lead in innovation and new product discovery. Dr. Guy has been actively involved in scientific innovation, medical research, and global drug development throughout his career. Prior to his role at GW, Dr. Guy served as President and CEO of Ethical Holdings plc, a NASDAQ-listed drug delivery company.
Doctor of Chemistry Complutense University of Madrid. Cannabis Research Group.
Ismael Galve-Roperh, Professor at the Complutense University (Madrid), investigates the mechanisms of action of cannabinoids in the nervous system and their pathophysiological implications. Among other contributions, he has worked on the development of two clinical trials to investigate the safety of cannabinoid treatment (glioblastoma multiforme and Huntington’s disease), the identification of neuronal changes induced by prenatal exposure to THC, as well as the development of several international patents. Currently, he coordinates the Ibero-American research network CannaLatan – Cyted.
José Carlos Bouso
Psychologist and Doctor of Pharmacology Autonomous University of Madrid.
Clinical Psychologist and Doctor of Pharmacology. He has developed his scientific activity at the Autonomous University of Madrid, at the Biomedical Research Institute IIB-SantPau in Barcelona and at the Hospital del Mar Institute for Medical Research in Barcelona (IMIM). During this time, he developed studies on the therapeutic effects of MDMA (“ecstasy”) and psychopharmacological studies on the acute and long-term neuropsychiatric effects of many substances, both synthetic and plant origin. As Scientific Director of ICEERS, José Carlos oversees studies on the potential benefits of psychoactive plants, mainly cannabis, ayahuasca and ibogaine, with the aim of improving public health. He is the co-author of numerous scientific articles and several book chapters.
Manuel Miranda Gallardo, graduated in History from the University of Seville and Master in Methods and advanced techniques in historical, artistic and geographical research from the UNED. He currently works as a professor of Geography and History at the IEDA center, belonging to the Junta de Andalucía.
Medical Cannabis Nurse, apcanna member.
Soraia graduated in Nursing from the Escola Superior de Enfermagem de Coimbra in 2015. she is an enthusiast in the field of Medicinal Cannabis and is a member of the Scientific Council of the Portuguese Observatory of Medicinal Cannabis, She has attended conferences in this field (Portugal Medical Cannabis, Cannabis Europe, CannX , CannabMed among others) and has obtained a Bachelor’s Degree in BPM for Medicinal Cannabis, a course taught by the Portuguese Observatory of Medicinal Cannabis in association with the Military Laboratory of Chemical and Pharmaceutical Products and the Faculty of Pharmacy of the University of Lisbon. She is the president of the General Assembly of apcanna, the Portuguese Cannabis Information Association, and she also provides nursing advice and supervision to medical cannabis patients through the KALAPA Clinic.
Researcher Institut Hospital del Mar d’Investigacions Médiques.
Degree in Philosophy and Anthropology. Masters degree on drug addiction from the University of Barcelona. He has been Deputy Director General of Drug Addiction of the Generalitat de Catalunya. Founding member of the Drug Policy Unit of the Autonomous University of Barcelona. He is part of the Cannabis Policy Study Group. He is a collaborating professor at the UOC. Currently Deputy Director of the ICEERS Foundation, where he has promoted the publication of popular articles and scientific publications on the phenomenon of Social Clubs, the creation of the Union of Patients for the Regulation of Cannabis, the Clinical Society of Endocannabinology, and the three editions of the Congress CANNABMED.
PhD Biology, Pompeu Fabra University.
Principal Investigator in various projects, Ester Aso has a degree in Biology from the University of Barcelona (2001). She received a doctorate in Health and Life Sciences from Pompeu Fabra University in 2008, under the supervision of Prof. Rafael Maldonado and Prof. Olga Valverde. During her predoctoral studies, she carried out research projects aimed at evaluating the involvement of the endogenous cannabinoid system (ECS) in affective disorders, such as depression and anxiety. From 2009 to February 2018 she was a postdoctoral researcher at the Institute of Neuropathology, Pathological Anatomy Service of the Bellvitge University Hospital, led by Professor Isidre Ferrer. Her research interests at the Institute of Neuropathology focused on the potential utility of cannabinoid compounds in treating Alzheimer’s disease.
Request information without obligation by filling in the following form
Or call us on: +34 983 390 716